Jan 26, 2023 · Washington, D.C. – U.S. Senator Elizabeth Warren (D-Mass.) sent a letter to Federal Trade Commission (FTC) Chair Lina Khan and FTC Commissioners Alvardo Bedoya and Rebecca Kelly Slaughter urging the agency to closely scrutinize two pending big pharmaceutical mergers: Amgen and Horizon Therapeutics, and Indivior and Opiant. In the letter, the ...

Nov 9, 2023 · Washington, D.C. - United States Senator Elizabeth Warren (D-Mass.) sent a letter to Federal Trade Commission (FTC) Chair Lina Khan and Commissioners Bedoya and Slaughter expressing disappointment with the FTC’s proposed consent order allowing pharmaceutical giant Amgen to move forward with its acquisition of Horizon Therapeutics (Horizon ...

Oct 10, 2024 · Washington, DC – U.S. Senator Elizabeth Warren (D-Mass.) sent a letter to Federal Trade Commission (FTC) Chair Lina Khan, urging the FTC to closely scrutinize a proposed merger between Novo Nordisk and contract development and manufacturing organization Catalent, and block the deal if it is found to be illegal under antitrust law. In the ...

Apr 19, 2023 · Led by Sens. Elizabeth Warren (Mass.) and Richard Blumenthal (Conn.) in the Senate, the lawmakers urged the FTC to stand strong and “resist calls” from businesses to postpone the rule or add carveouts and instead “act quickly to …

Jan 26, 2023 · Sen. Elizabeth Warren, an outspoken critic of corporate consolidation, wrote to the U.S. Federal Trade Commission to express concern about two pending pharmaceutical deals.

Oct 29, 2024 · Sen. Elizabeth Warren (D-Mass.) is urging the Federal Trade Commission to scrutinize recent deals from McKesson and Cardinal Health to buy oncology practices, saying those transactions pose...

Apr 15, 2024 · Senator Elizabeth Warren (D-MA) has written a letter to the Federal Trade Commission, saying that TurboTax “continues to relentlessly upsell” customers while also directing them away from...

Sep 19, 2023 · US Senator Elizabeth Warren has once again reiterated the need for more strict antitrust enforcement, backing efforts by Federal Trade Commission Chair Lina Khan and the Justice Department to...

Elizabeth Warren (D-MA) is calling on the Federal Trade Commission to carefully evaluate Novo Nordisk Foundation's planned $16.5 billion acquisition of Catalent (NYSE: CTLT).

Oct 10, 2024 · Sen. Elizabeth Warren (D-MA) is calling on the Federal Trade Commission to carefully evaluate Novo Nordisk Foundation's planned $16.5 billion acquisition of Catalent (NYSE:CTLT).